Peng F, Hu N, Liu Y, Xing C, Luo L, Li X
Front Microbiol. 2023; 14:1255935.
PMID: 37954238
PMC: 10634548.
DOI: 10.3389/fmicb.2023.1255935.
Hou F, Zhang Y, Liu X, Murad Y, Xu J, Yu Z
Nat Commun. 2023; 14(1):5925.
PMID: 37739969
PMC: 10516993.
DOI: 10.1038/s41467-023-41628-5.
Lin D, Shen Y, Liang T
Signal Transduct Target Ther. 2023; 8(1):156.
PMID: 37041165
PMC: 10090134.
DOI: 10.1038/s41392-023-01407-6.
Khlusevich Y, Matveev A, Emelyanova L, Goncharova E, Golosova N, Pereverzev I
Viruses. 2022; 14(6).
PMID: 35746695
PMC: 9227246.
DOI: 10.3390/v14061224.
Ahsendorf H, Diesterbeck U, Hotop S, Winkler M, Bronstrup M, Czerny C
Viruses. 2022; 14(2).
PMID: 35215792
PMC: 8879190.
DOI: 10.3390/v14020197.
Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.
Diesterbeck U, Ahsendorf H, Frenzel A, Sharifi A, Schirrmann T, Czerny C
Vaccines (Basel). 2021; 9(11).
PMID: 34835240
PMC: 8619513.
DOI: 10.3390/vaccines9111308.
Design and Engineering of Deimmunized Vaccinia Viral Vectors.
Song K, Viskovska M
Biomedicines. 2020; 8(11).
PMID: 33187060
PMC: 7697509.
DOI: 10.3390/biomedicines8110491.
Virus-Receptor Interactions: Structural Insights For Oncolytic Virus Development.
Jayawardena N, Burga L, Poirier J, Bostina M
Oncolytic Virother. 2019; 8:39-56.
PMID: 31754615
PMC: 6825474.
DOI: 10.2147/OV.S218494.
Species-Specific Conservation of Linear Antigenic Sites on Vaccinia Virus A27 Protein Homologs of Orthopoxviruses.
Ahsendorf H, Gan L, Eltom K, Abd El Wahed A, Hotop S, Roper R
Viruses. 2019; 11(6).
PMID: 31146446
PMC: 6631127.
DOI: 10.3390/v11060493.
Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets.
Meng X, Kaever T, Yan B, Traktman P, Zajonc D, Peters B
Virology. 2018; 518:284-292.
PMID: 29558682
PMC: 5911218.
DOI: 10.1016/j.virol.2018.03.005.
Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies.
Chervyakova O, Zaitsev V, Iskakov B, Tailakova E, Strochkov V, Sultankulova K
Viruses. 2016; 8(6).
PMID: 27338444
PMC: 4926179.
DOI: 10.3390/v8060159.
Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.
Kaever T, Meng X, Matho M, Schlossman A, Li S, Sela-Culang I
J Virol. 2014; 88(19):11339-55.
PMID: 25031354
PMC: 4178804.
DOI: 10.1128/JVI.01491-14.
T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.
Davies D, Chun S, Hermanson G, Tucker J, Jain A, Nakajima R
J Immunol. 2014; 193(4):1812-27.
PMID: 25024392
PMC: 4119580.
DOI: 10.4049/jimmunol.1400663.
Poxvirus cell entry: how many proteins does it take?.
Moss B
Viruses. 2012; 4(5):688-707.
PMID: 22754644
PMC: 3386626.
DOI: 10.3390/v4050688.
Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling.
Izmailyan R, Hsao J, Chung C, Chen C, Hsu P, Liao C
J Virol. 2012; 86(12):6677-87.
PMID: 22496232
PMC: 3393588.
DOI: 10.1128/JVI.06860-11.
A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
Liu Q, Huang W, Nie J, Zhu R, Gao D, Song A
PLoS One. 2012; 7(3):e33392.
PMID: 22438922
PMC: 3306400.
DOI: 10.1371/journal.pone.0033392.
The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry.
Foo C, Whitbeck J, Ponce-de-Leon M, Saw W, Cohen G, Eisenberg R
J Virol. 2012; 86(10):5437-51.
PMID: 22398293
PMC: 3347306.
DOI: 10.1128/JVI.06703-11.
The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.
Schroeder N, Chung C, Chen C, Liao C, Chang W
J Virol. 2012; 86(9):4868-82.
PMID: 22345471
PMC: 3347329.
DOI: 10.1128/JVI.06610-11.
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
Golden J, Zaitseva M, Kapnick S, Fisher R, Mikolajczyk M, Ballantyne J
Virol J. 2011; 8:441.
PMID: 21933385
PMC: 3192780.
DOI: 10.1186/1743-422X-8-441.
An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies.
Xu C, Meng X, Yan B, Crotty S, Deng J, Xiang Y
Virology. 2011; 418(1):67-73.
PMID: 21810533
PMC: 3163717.
DOI: 10.1016/j.virol.2011.06.029.